Cargando…
VEGF-B: a more balanced approach toward cardiac neovascularization?
There is an urgent need for new pharmacologic approaches to combat the clinical consequences of ischemic cardiomyopathy. In this issue of EMBO Molecular Medicine, Kivelä et al show that transgenic expression of VEGF-B in the rat heart leads to expansion of the coronary arterial tree and an increase...
Autores principales: | Kupatt, Christian, Hinkel, Rabea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958304/ https://www.ncbi.nlm.nih.gov/pubmed/24521742 http://dx.doi.org/10.1002/emmm.201303730 |
Ejemplares similares
-
VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitor
por: Favara, David M, et al.
Publicado: (2014) -
You can teach an old dog new tricks: angiopoietin-1 instructs Tie2(pos) myeloid cells to promote neovascularization in ischemic limbs
por: Emanueli, Costanza, et al.
Publicado: (2013) -
Tipping the MYC–MIZ1 balance: targeting the HUWE1 ubiquitin ligase selectively
blocks MYC-activated genes
por: Schaub, Franz X, et al.
Publicado: (2014) -
More than the sum of its parts: new mouse models for dissecting the genetic complexities of Williams–Beuren syndrome
por: Meyer-Lindenberg, Andreas
Publicado: (2009) -
Novel approach to inhibiting chemokine function
por: Ling, Morris F, et al.
Publicado: (2011)